ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Downregulation of HDAC9 by the ketone metabolite β-hydroxybutyrate suppresses vascular calcification

Lan, Zirong; Chen, An; Li, Li; Ye, Yuanzhi; Liang, Qingchun; Dong, Qianqian; Wang, Siyi; Fu, Mingwei; Li, Yining; Liu, Xiaoyu; Zhu, Zhenyu; Ou, Jing-Song; Qiu, Xiaozhong; Lu, Lihe*; Yan, Jianyun*南方医科大学; 中山大学; 1; 5
Journal of Pathology2022-11DOI: 10.1002/path.5992
6被引10阅读
引用收藏
分享

摘要

Vascular calcification is an actively regulated process resembling bone formation and contributes to the cardiovascular morbidity and mortality of chronic kidney disease (CKD). However, an effective therapy for vascular calcification is still lacking. The ketone body beta-hydroxybutyrate (BHB) has been demonstrated to have health-promoting effects including anti-inflammation and cardiovascular protective effects. However, whether BHB protects against vascular calcification in CKD remains unclear. In this study, Alizarin Red staining and calcium content assay showed that BHB reduced calcification of vascular smooth muscle cells (VSMCs) and arterial rings. Of note, compared with CKD patients without thoracic calcification, serum BHB levels were lower in CKD patients with thoracic calcification. Supplementation with 1,3-butanediol (1,3-B), the precursor of BHB, attenuated aortic calcification in CKD rats and VitD3-overloaded mice. Furthermore, RNA-seq analysis revealed that BHB downregulated HDAC9, which was further confirmed by RT-qPCR and western blot analysis. Both pharmacological inhibition and knockdown of HDAC9 attenuated calcification of human VSMCs, while overexpression of HDAC9 exacerbated calcification of VSMCs and aortic rings, indicating that HDAC9 promotes vascular calcification under CKD conditions. Of note, BHB treatment antagonized HDAC9-induced vascular calcification. In addition, HDAC9 overexpression activated the NF-kappa B signaling pathway and inhibition of NF-kappa B attenuated HDAC9-induced VSMC calcification, suggesting that HDAC9 promotes vascular calcification via activation of NF-kappa B. In conclusion, our study demonstrates that BHB supplementation inhibits vascular calcification in CKD via modulation of the HDAC9-dependent NF-kappa B signaling pathway. Moreover, we unveil a crucial mechanistic role of HDAC9 in vascular calcification under CKD conditions; thus, nutritional intervention or pharmacological approaches to enhance BHB levels could act as promising therapeutic strategies to target HDAC9 for the treatment of vascular calcification in CKD.

学科与关键词

关键词
beta-hydroxybutyrateHDAC9vascular calcificationvascular smooth muscle cellchronic kidney disease
相关
加载中…
  • The short-chain fatty acid butyrate accelerates vascular calcification via regulation of histone deacetylases and NF-?B signaling
    Zhong, Hui; Yu, Hongjiao; Chen, Jiaxin; Mok, Simon Wing Fai; Tan, Xiao; Zhao, Bohou; He, Shengping; Lan, Lan; Fu, Xiaodong*; Chen, Guojun*; Zhu, Dongxing*Vascular Pharmacology, 2022, 146: 107096.被引 6
  • Dihydromyricetin ameliorates vascular calcification in chronic kidney disease by targeting AKT signaling
    Feng, Liyun; Que, Dongdong; Li, Zehua; Zhong, Xinglong; Yan, Jing; Wei, Jintao; Zhang, Xiuli; Yang, Pingzhen; Ou, Caiwen*; Chen, Minsheng*Clinical Science, 2021, 135(21): 2483-2502.被引 6
  • CCAAT/Enhancer-Binding Protein Alpha Is a Novel Regulator of Vascular Smooth Muscle Cell Osteochondrogenic Transition and Vascular Calcification
    Chen, Pengyuan; Hong, Wanzi; Chen, Ziying; Gordillo-Martinez, Flora; Wang, Siying; Fan, Hualin; Liu, Yuanhui; Dai, Yining; Wang, Bo; Jiang, Lei*; Yu, Hongjiao*; He, PengCheng*Frontiers in Physiology, 2022, 13: 755371.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Pathology
发表日期
2022-11
卷期
第 258 卷, 第 3 期
页码
213-226
DOI
10.1002/path.5992
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82070246, 81870190, 82170414]; National Key R&D Program of China [2021YFA0805100]; Guangdong Basic and Applied Basic Research Foundation [2021A1515010752, 2019A1515010682, 2021A1515011044, 2015A030312009]; China Postdoctoral Science Foundation [F121ZJ0234]

作者

  • L

    Lan, Zirong (第一作者)

    southern med univ

  • C

    Chen, An

    southern med univ

查看全部 15 位作者收起作者
  • L

    Li, Li

  • Y

    Ye, Yuanzhi

    southern med univ

  • L

    Liang, Qingchun

    southern med univ

  • D

    Dong, Qianqian

    southern med univ

  • W

    Wang, Siyi

    southern med univ

  • F

    Fu, Mingwei

    southern med univ

  • L

    Li, Yining

    southern med univ

  • L

    Liu, Xiaoyu

    southern med univ

  • Z

    Zhu, Zhenyu

    southern med univ

  • O

    Ou, Jing-Song

    1 · sun yat sen univ

  • Q

    Qiu, Xiaozhong

    southern med univ · 5

  • L

    Lu, Lihe (通讯)

    sun yat sen univ

  • Y

    Yan, Jianyun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417